• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物性肝损伤

Drug-induced hepatic injury.

作者信息

Farrell G C

机构信息

Storr Liver Unit, University of Sydney at Westmead Hospital, NSW, Australia.

出版信息

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S242-50. doi: 10.1111/j.1440-1746.1997.tb00507.x.

DOI:10.1111/j.1440-1746.1997.tb00507.x
PMID:9407344
Abstract

Drugs and other chemical toxins account for less than 5% of cases of jaundice or acute hepatitis and fewer cases of chronic liver disease, but they are an important cause of more severe types of hepatic injury. Drug reactions produce an array of hepatic lesions that mimic all known hepatobiliary diseases; this poses a diagnostic challenge for physicians and pathologists. Diagnosis of drug-induced hepatic injury is circumstantial, with positive rechallenge being the only factor that unequivocally implicates a particular agent. Nonetheless, other aspects of the temporal relationship between drug ingestion and adverse reaction, exclusion of other diseases, the presence of extrahepatic features of drug hypersensitivity and some findings on liver biopsy can lend support to the diagnosis. Some of these issues will be explored in this review by considering contemporary paradigms of drug-induced hepatic injury. Factors that predispose to dose-dependent hepatic injury will be considered in relation to acetaminophen, an example of acute hepatotoxicity, and methotrexate, an agent that can produce hepatic fibrosis. Flucloxacillin will be discussed as an example of drug-induced cholestatic hepatitis often associated with prolonged cholestasis and the vanishing bile duct syndrome. Minocycline and diclofenac will be mentioned as two drugs for which drug hepatitis is an exceedingly rare complication. Finally, the evidence that Chinese herbal medicines can be hepatotoxic will be reviewed.

摘要

药物和其他化学毒素导致的黄疸或急性肝炎病例不到5%,导致的慢性肝病病例更少,但它们是更严重类型肝损伤的重要原因。药物反应会产生一系列肝脏病变,这些病变可模仿所有已知的肝胆疾病;这给医生和病理学家带来了诊断挑战。药物性肝损伤的诊断是基于间接证据的,再次用药阳性是唯一能明确表明某一特定药物致病的因素。尽管如此,药物摄入与不良反应之间的时间关系的其他方面、排除其他疾病、药物超敏反应的肝外特征的存在以及肝活检的一些发现都可为诊断提供支持。在本综述中,将通过考虑药物性肝损伤的当代范例来探讨其中的一些问题。将结合对乙酰氨基酚(急性肝毒性的一个例子)和甲氨蝶呤(一种可导致肝纤维化的药物)来考虑易导致剂量依赖性肝损伤的因素。氟氯西林将作为药物性胆汁淤积性肝炎的一个例子进行讨论,这种肝炎常与长期胆汁淤积和胆管消失综合征相关。米诺环素和双氯芬酸将作为药物性肝炎极为罕见并发症的两种药物被提及。最后,将综述中草药具有肝毒性的证据。

相似文献

1
Drug-induced hepatic injury.药物性肝损伤
J Gastroenterol Hepatol. 1997 Oct;12(9-10):S242-50. doi: 10.1111/j.1440-1746.1997.tb00507.x.
2
Drug associated hepatic reactions in New Zealand: 21 years experience.新西兰与药物相关的肝脏反应:21年经验
N Z Med J. 1996 Aug 23;109(1028):315-9.
3
Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?氟氯西林相关性胆汁淤积性肝炎。澳大利亚和瑞典的一种流行病?
Eur J Clin Pharmacol. 1995;49(1-2):81-5. doi: 10.1007/BF00192363.
4
Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.一名成年患者布洛芬治疗后出现伴有高脂血症的消失胆管综合征:病例报告
BMC Gastroenterol. 2018 Sep 29;18(1):142. doi: 10.1186/s12876-018-0869-9.
5
[Hepatic tolerance of atypical antipsychotic drugs].[非典型抗精神病药物的肝脏耐受性]
Encephale. 2002 Nov-Dec;28(6 Pt 1):542-51.
6
Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.某三级医疗中心药物性肝损伤的发生率及病理特征
Hum Pathol. 2017 Oct;68:92-98. doi: 10.1016/j.humpath.2017.08.029. Epub 2017 Sep 2.
7
Drug- and chemical-induced cholestasis.药物和化学物质所致胆汁淤积。
Clin Liver Dis. 1999 Aug;3(3):433-64, vii. doi: 10.1016/s1089-3261(05)70079-9.
8
Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy.氟氯西林所致肝病:活检及尸检的组织病理学发现
Pathology. 1993 Jul;25(3):223-8. doi: 10.3109/00313029309066576.
9
Flucloxacillin-induced liver injury.氟氯西林所致肝损伤。
Toxicology. 2008 Dec 30;254(3):158-63. doi: 10.1016/j.tox.2008.08.009. Epub 2008 Aug 29.
10
Antibacterial-induced hepatotoxicity. Incidence, prevention and management.抗菌药物所致肝毒性。发生率、预防及管理
Drug Saf. 1996 Jul;15(1):79-85. doi: 10.2165/00002018-199615010-00007.

引用本文的文献

1
Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity.对一组纳米材料的临床前 2D 和 3D 毒性反应;NBM 诱导的肝毒性的比较评估。
Drug Deliv Transl Res. 2022 Sep;12(9):2157-2177. doi: 10.1007/s13346-022-01170-1. Epub 2022 Jun 28.
2
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.非酒精性脂肪性肝病作为药物性肝毒性危险因素的作用。
J Clin Transl Res. 2017 Feb;3(Suppl 1):212-232. doi: 10.18053/jctres.03.2017S1.006. Epub 2017 Feb 12.
3
Drug-induced hepatotoxicity in a tertiary care hospital in rural South India.
印度南部农村一家三级医疗中心的药物性肝毒性
N Am J Med Sci. 2012 Feb;4(2):90-3. doi: 10.4103/1947-2714.93385.
4
A cross-sectional investigation of chronic exposure to microcystin in relationship to childhood liver damage in the Three Gorges Reservoir Region, China.中国三峡库区儿童肝损伤与长期暴露于微囊藻毒素的横断面研究。
Environ Health Perspect. 2011 Oct;119(10):1483-8. doi: 10.1289/ehp.1002412. Epub 2011 May 11.
5
Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity.利福平激活的人孕烷X受体和CYP3A4诱导增强对乙酰氨基酚诱导的毒性。
Drug Metab Dispos. 2009 Aug;37(8):1611-21. doi: 10.1124/dmd.109.027565. Epub 2009 May 21.
6
Gastrointestinal tolerability of metamizol, acetaminophen, and diclofenac in subchronic treatment in rats.安乃近、对乙酰氨基酚和双氯芬酸在大鼠亚慢性治疗中的胃肠道耐受性
Dig Dis Sci. 2002 Dec;47(12):2791-8. doi: 10.1023/a:1021077810548.
7
Diagnostic approach to patients with cholestatic jaundice.胆汁淤积性黄疸患者的诊断方法。
World J Gastroenterol. 1999 Jun;5(3):252-262. doi: 10.3748/wjg.v5.i3.252.
8
Drug-Induced Liver Disease.药物性肝病
Curr Treat Options Gastroenterol. 2000 Dec;3(6):457-462. doi: 10.1007/s11938-000-0034-7.
9
Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data.米诺环素治疗痤疮相关的肝损伤:已发表文献及药物警戒数据的系统评价
Drug Saf. 2000 Oct;23(4):333-49. doi: 10.2165/00002018-200023040-00006.
10
Is there any use for nontraditional or alternative therapies in patients with chronic liver disease?非传统或替代疗法对慢性肝病患者有任何用处吗?
Curr Gastroenterol Rep. 1999 Feb-Mar;1(1):50-6. doi: 10.1007/s11894-999-0087-2.